Severe Obesity and Heart Failure

      Obesity is associated with reduced mortality in some patients hospitalized for heart failure (HF). In this analysis, we determine if this nonlinear relation, referred to as the obesity paradox, extends to secondary outcomes in patients diagnosed with severe obesity. This is a retrospective cohort study using the 2017 and 2018 National Inpatient Sample that includes adults hospitalized for HF. Patients with diagnosis codes specifying severe obesity, nonsevere obesity, or without obesity are compared. The primary outcome is mortality. Secondary outcomes include the length of stay (LOS), total charges, and cardiogenic shock (CS). Multivariate regression is used to adjust for demographics and co-morbidities. A total of 2,439,845 hospitalizations are included. A decreased mortality is found in nonsevere obesity (odds ratio 0.74, 95% confidence interval 0.69 to 0.80, p = 0.000), affirming the obesity paradox. However, this decreased mortality is not found in severe obesity (odds ratio 1.01, 95% confidence interval 0.94 to 1.08, p = 0.766). Severe obesity and nonsevere obesity are also associated with less CS and increased LOS compared with non-obese patients. Severe obesity is associated with increased total charges. In conclusion, a nonlinear, U-shaped relation between obesity and mortality in patients hospitalized for HF is demonstrated, where those not obese and those severely obese experience greater mortality compared with the nonseverely obese. However, for secondary outcomes of CS, LOS, and total charges, the relation is linear and therefore not interpreted as paradoxical. More information is needed using the adiposity-based chronic disease model to characterize complex relations between obesity and mortality.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. World Health Organization. Obesity and overweight. Available at: Accessed in November 30, 2021.

        • Powell-Wiley TM
        • Poirier P
        • Burke LE
        • Després JP
        • Gordon-Larsen P
        • Lavie CJ
        • Lear SA
        • Ndumele CE
        • Neeland IJ
        • Sanders P
        • St-Onge MP
        • American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council
        Obesity and cardiovascular disease: a scientific statement from the American Heart Association.
        Circulation. 2021; 143: e984-e1010
        • Kenchaiah S
        • Evans JC
        • Levy D
        • Wilson PWF
        • Benjamin EJ
        • Larson MG
        • Kannel WB
        • Vasan RS
        Obesity and the risk of heart failure.
        N Engl J Med. 2002; 347: 305-313
        • Fonarow GC
        • Srikanthan P
        • Costanzo MR
        • Cintron GB
        • Lopatin M
        • ADHERE Scientific Advisory Committee and Investigators
        An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.
        Am Heart J. 2007; 153: 74-81
      2. Healthcare Cost and Utilization Project (HCUP). Overview of the National (Nationwide) Inpatient Sample (NIS). Available at: Accessed on December 10, 2021.

      3. Healthcare Cost and Utilization Project (HCUP). Producing national HCUP estimates. Available at: Accessed on February 22, 2022.

        • Nagarajan V
        • Cauthen CA
        • Starling RC
        • Tang WH
        Prognosis of morbid obesity patients with advanced heart failure.
        Congest Heart Fail. 2013; 19: 160-164
        • Kapoor JR
        • Heidenreich PA.
        Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship.
        Am Heart J. 2010; 159: 75-80
        • Carbone S
        • Lavie CJ
        • Arena R
        Obesity and heart failure: focus on the obesity paradox.
        Mayo Clin Proc. 2017; 92: 266-279
        • Mechanick JI
        • Hurley DL
        • Garvey WT
        Adiposity-based chronic disease as a new diagnostic Term: the American Association of Clinical Endocrinologists and American College of Endocrinology position statement.
        Endocr Pract. 2017; 23: 372-378
        • Mechanick JI
        • Farkouh ME
        • Newman JD
        • Garvey WT
        Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review.
        J Am Coll Cardiol. 2020; 75: 525-538
        • Garvey WT
        • Mechanick JI
        • Brett EM
        • Garber AJ
        • Hurley DL
        • Jastreboff AM
        • Nadolsky K
        • Pessah-Pollack R
        • Plodkowski R
        • Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines
        American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.
        Endocr Pract. 2016; 22: 1-203
        • De Schutter A
        • Lavie CJ
        • Arce K
        • Menendez SG
        • Milani RV
        Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease.
        J Cardiopulm Rehabil Prev. 2013; 33: 77-83
        • Deurenberg P
        • Yap M
        • van Staveren WA
        Body mass index and percent body fat: a meta-analysis among different ethnic groups.
        Int J Obes Relat Metab Disord. 1998; 22: 1164-1171
        • Garvey WT
        • Mechanick JI
        Proposal for a scientifically correct and medically actionable disease classification system (ICD) for obesity.
        Obesity (Silver Spring). 2020; 28: 484-492
        • Lavie CJ
        • Osman AF
        • Milani RV
        • Mehra MR
        Body composition and prognosis in chronic systolic heart failure: the obesity paradox.
        Am J Cardiol. 2003; 91: 891-894
        • Rossignol P
        • Masson S
        • Barlera S
        • Girerd N
        • Castelnovo A
        • Zannad F
        • Clemenza F
        • Tognoni G
        • Anand IS
        • Cohn JN
        • Anker SD
        • Tavazzi L
        • Latini R
        • GISSI-HF and Val-HeFT Investigators
        Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.
        Eur J Heart Fail. 2015; 17: 424-433
        • von Haehling S
        • Garfias Macedo T
        • Valentova M
        • Anker MS
        • Ebner N
        • Bekfani T
        • Haarmann H
        • Schefold JC
        • Lainscak M
        • Cleland JGF
        • Doehner W
        • Hasenfuss G
        • Anker SD
        Muscle wasting as an independent predictor of survival in patients with chronic heart failure.
        J Cachexia Sarcopenia Muscle. 2020; 11: 1242-1249
        • Cicoira M
        • Zanolla L
        • Franceschini L
        • Rossi A
        • Golia G
        • Zamboni M
        • Tosoni P
        • Zardini P
        Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure.
        J Am Coll Cardiol. 2001; 37: 2080-2085
        • Guazzi M
        • Adams V
        • Conraads V
        • Halle M
        • Mezzani A
        • Vanhees L
        • Arena R
        • Fletcher GF
        • Forman DE
        • Kitzman DW
        • Lavie CJ
        • Myers J
        • European Association for Cardiovascular Prevention & Rehabilitation, American Heart Association. EACPR/AHA Scientific Statement
        Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.
        Circulation. 2012; 126: 2261-2274
        • Osman AF
        • Mehra MR
        • Lavie CJ
        • Nunez E
        • Milani RV
        The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure.
        J Am Coll Cardiol. 2000; 36: 2126-2131
        • Tian S
        • Xu Y
        Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies.
        Geriatr Gerontol Int. 2016; 16: 155-166
        • Yancy CW
        • Jessup M
        • Bozkurt B
        • Butler J
        • Casey DE
        • Drazner MH
        • Fonarow GC
        • Geraci SA
        • Horwich T
        • Januzzi JL
        • Johnson MR
        • Kasper EK
        • Levy WC
        • Masoudi FA
        • McBride PE
        • McMurray JJV
        • Mitchell JE
        • Peterson PN
        • Riegel B
        • Sam F
        • Stevenson LW
        • Tang WHW
        • Tsai EJ
        • Wilkoff BL
        • American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines
        2013 ACCF/AHA guideline for the management of heart failure.
        J Am Coll Cardiol. 2013; 62: e147-e239
        • McDonagh TA
        • Metra M
        • Adamo M
        • Gardner RS
        • Baumbach A
        • Böhm M
        • Burri H
        • Butler J
        • Čelutkienė J
        • Chioncel O
        • Cleland JGF
        • Coats AJS
        • Crespo-Leiro MG
        • Farmakis D
        • Gilard M
        • Heymans S
        • Hoes AW
        • Jaarsma T
        • Jankowska EA
        • Lainscak M
        • Lam CSP
        • Lyon AR
        • McMurray JJV
        • Mebazaa A
        • Mindham R
        • Muneretto C
        • Francesco Piepoli M
        • Price S
        • Rosano GMC
        • Ruschitzka F
        • Kathrine Skibelund A
        • ESC Scientific Document Group
        2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
        Eur Heart J. 2021; 42: 3599-3726